Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.

about

Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site.

P2860

Q48105075-B8338B7A-35AA-42A5-BD45-FAE76AA0B8CA

P2860

Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.

Item

http://www.wikidata.org/entity/Q38949284

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Novel Bacterial Topoisomerase ...... ainst Drug-Resistant Bacteria.

@en

type

Item

label

Novel Bacterial Topoisomerase ...... ainst Drug-Resistant Bacteria.

@en

prefLabel

Novel Bacterial Topoisomerase ...... ainst Drug-Resistant Bacteria.

@en

P1476

Novel Bacterial Topoisomerase ...... gainst Drug-Resistant Bacteria

@en

P2093

Andrew J Ratcliffe

http://www.w3.org/2001/XMLSchema#string

Anne-Marie Salisbury

http://www.w3.org/2001/XMLSchema#string

Cédric Charrier

http://www.w3.org/2001/XMLSchema#string

Emmanuel Moyo

http://www.w3.org/2001/XMLSchema#string

Gary Nelson

http://www.w3.org/2001/XMLSchema#string

Hayley S Butler

http://www.w3.org/2001/XMLSchema#string

Ian R Cooper

http://www.w3.org/2001/XMLSchema#string

Jonathan Cheung

http://www.w3.org/2001/XMLSchema#string

Mark Craighead

http://www.w3.org/2001/XMLSchema#string

Mark Pichowicz

http://www.w3.org/2001/XMLSchema#string

P2860

10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America

Confronting the challenges of discovery of novel antibacterial agents

Type IIA topoisomerase inhibition by a new class of antibacterial agents

Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases

Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases

Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE

Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents

In vitro activity of new quinolones against Clostridium difficile.

Challenges of antibacterial discovery

Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition.

P31

scholarly article

P356

10.1128/AAC.02100-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David McGarry

P577

2017-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28223393

http://www.w3.org/2001/XMLSchema#string

P932

5404544

http://www.w3.org/2001/XMLSchema#string

Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.

about

P2860

P2860

Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932